As the Brexit Clock Ticks Down, MHRA Issues Slew of Guidances

Drug Industry Daily
A A
With the UK’s possible exit from the EU a little over a week away, the Medicines and Healthcare products Regulatory Agency (MHRA) released 16 new and revised guidances to cover a no-deal exit scenario.

To View This Article:

Login

Subscribe To Drug Industry Daily